Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong
· Delayed Price · Currency is HKD 5.10
+0.03 (0.59%)
Apr 28, 2026, 1:35 PM HKT
Jiangsu Recbio Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Operating Revenue | 12.73 | - | - | - | - | Upgrade
|
| Other Revenue | - | 27.01 | 30.38 | 5.33 | 6.2 | Upgrade
|
| Revenue | 12.73 | 27.01 | 30.38 | 5.33 | 6.2 | Upgrade
|
| Revenue Growth (YoY) | -52.88% | -11.10% | 470.46% | -14.10% | 325.17% | Upgrade
|
| Cost of Revenue | 3.49 | 11.06 | 8.04 | - | - | Upgrade
|
| Gross Profit | 9.24 | 15.95 | 22.34 | 5.33 | 6.2 | Upgrade
|
| Selling, General & Admin | 92.95 | 111.67 | 152.24 | 163.96 | 146.51 | Upgrade
|
| Research & Development | 520.7 | 476.12 | 487.85 | 716.44 | 472.95 | Upgrade
|
| Operating Expenses | 613.65 | 587.79 | 640.09 | 880.4 | 619.46 | Upgrade
|
| Operating Income | -604.41 | -571.85 | -617.75 | -875.08 | -613.26 | Upgrade
|
| Interest Expense | -23.96 | -18.9 | -13.57 | -3.53 | -56.31 | Upgrade
|
| Interest & Investment Income | 2.8 | 21.38 | 45.58 | 23.98 | 10.36 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.3 | 8.97 | 17.5 | 115.06 | -8.49 | Upgrade
|
| Other Non Operating Income (Expenses) | 17.22 | 2.29 | -2.12 | 0.02 | -1.06 | Upgrade
|
| EBT Excluding Unusual Items | -608.04 | -558.1 | -570.36 | -739.55 | -668.76 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 3.56 | 11.22 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.11 | 0.06 | 6.61 | - | -0.02 | Upgrade
|
| Asset Writedown | -0.09 | -3.86 | -8.69 | - | - | Upgrade
|
| Pretax Income | -608.23 | -561.9 | -572.44 | -736 | -657.57 | Upgrade
|
| Income Tax Expense | 2.16 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -610.39 | -561.9 | -572.44 | -736 | -657.57 | Upgrade
|
| Minority Interest in Earnings | - | -0.49 | 0.49 | 13.29 | 0.01 | Upgrade
|
| Net Income | -610.39 | -562.39 | -571.96 | -722.7 | -657.56 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | -4.93 | - | - | - | Upgrade
|
| Net Income to Common | -610.39 | -557.46 | -571.96 | -722.7 | -657.56 | Upgrade
|
| Shares Outstanding (Basic) | 531 | 479 | 481 | 474 | 421 | Upgrade
|
| Shares Outstanding (Diluted) | 531 | 479 | 481 | 474 | 421 | Upgrade
|
| Shares Change (YoY) | 11.01% | -0.50% | 1.42% | 12.52% | 36.60% | Upgrade
|
| EPS (Basic) | -1.15 | -1.16 | -1.19 | -1.52 | -1.56 | Upgrade
|
| EPS (Diluted) | -1.15 | -1.16 | -1.19 | -1.52 | -1.56 | Upgrade
|
| Free Cash Flow | - | -636.66 | -850.11 | -876.27 | -710.79 | Upgrade
|
| Free Cash Flow Per Share | - | -1.33 | -1.77 | -1.85 | -1.69 | Upgrade
|
| Gross Margin | 72.61% | 59.05% | 73.54% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -4749.39% | -2117.56% | -2033.60% | -16433.33% | -9892.89% | Upgrade
|
| Profit Margin | -4796.40% | -2064.30% | -1882.86% | -13571.89% | -10607.53% | Upgrade
|
| Free Cash Flow Margin | - | -2357.56% | -2798.55% | -16455.78% | -11466.17% | Upgrade
|
| EBITDA | -533.62 | -501.05 | -569.87 | -847.67 | -598.36 | Upgrade
|
| D&A For EBITDA | 70.79 | 70.79 | 47.88 | 27.41 | 14.9 | Upgrade
|
| EBIT | -604.41 | -571.85 | -617.75 | -875.08 | -613.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.